Literature DB >> 29473507

Oxidative Stress and Decreased Mitochondrial Superoxide Dismutase 2 and Peroxiredoxins 1 and 4 Based Mechanism of Concurrent Activation of AMPK and mTOR in Alzheimer's Disease.

Shohreh Majd1, John H T Power2.   

Abstract

BACKGROUND: Emerging evidence supports the hypothesis that metabolism dysfunction is involved in pathogenesis of Alzheimer's disease (AD). One aspect of metabolic dysfunction includes dysregulation of adenosine monophosphate kinase protein kinase (AMPK) and mammalian target of rapamycin (mTOR) metabolic axis, which is extensively present in some of the leading causes of AD such as cerebrovascular diseases, type 2 diabetes and brain ischaemic events. While the molecular basis underlying this metabolic dysregulation remains a significant challenge, mitochondrial dysfunction due to aging appears to be an essential factor to activate AMPK/mTOR signaling pathway, leading to abnormal neuronal energy metabolism and AD pathology.
METHODS: Using immunofluorescent imaging by Lecia confocal microscopy, we analyzed the activation of AMPK/mTOR. Concurrently, the level of mitochondrial antioxidant enzymes of superoxide dismutase 2 (SOD2) and peroxiredoxin 1 and 4 (p1 and p4) along with protein and DANA oxidation were examined to in postmortem brains of AD (n= 8) and normal (n= 7) subjects to evaluate the metabolism dysfunction role in AD pathology.
RESULTS: In spite of AMPK inhibitory control on mTOR, concurrent phosphorylation of AMPK and mTOR (p-AMPK and p-mTOR) was observed in AD brains with high colocalization with hyperphosphorylated tau. Mitochondrial antioxidant enzymes of SOD2 and p1 and p4 were substantially decreased in p-AMPK, p-mTOR and p-tau positive cells along with higher levels of DNA and protein oxidation.
CONCLUSION: Collectively, we conclude that AMPK and mTOR metabolic axis is highly activated in AD brains. While the inhibitory link between AMPK and mTOR seems to be disrupted, we suggest oxidative stress as the underlying mechanism for concurrent activation of AMPK and mTOR in AD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer’s disease; adenosine monophosphate kinase proteinzzm321990kinase; mammalian target for rapamycin; mitochondrial antioxidant enzymes; oxidative stress; peroxiredoxin; superoxide dismutase; tau phosphorylation.

Mesh:

Substances:

Year:  2018        PMID: 29473507     DOI: 10.2174/1567205015666180223093020

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  16 in total

1.  Editorial: Current Trends in Medicinal Plant Research and Neurodegenerative Disorders.

Authors:  Muhammad Ayaz; Tahir Ali; Abdul Sadiq; Farhat Ullah; Muhammad Imran Naseer
Journal:  Front Pharmacol       Date:  2022-06-30       Impact factor: 5.988

Review 2.  The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?

Authors:  Elham Razani; Atieh Pourbagheri-Sigaroodi; Ava Safaroghli-Azar; Anahita Zoghi; Mahsa Shanaki-Bavarsad; Davood Bashash
Journal:  Cell Stress Chaperones       Date:  2021-08-13       Impact factor: 3.667

Review 3.  mTOR in Alzheimer disease and its earlier stages: Links to oxidative damage in the progression of this dementing disorder.

Authors:  M Perluigi; F Di Domenico; E Barone; D A Butterfield
Journal:  Free Radic Biol Med       Date:  2021-04-30       Impact factor: 8.101

Review 4.  Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale.

Authors:  Owen Sanders; Lekshmy Rajagopal
Journal:  J Alzheimers Dis Rep       Date:  2020-06-16

5.  A Proteomic Approach to Uncover Neuroprotective Mechanisms of Oleocanthal against Oxidative Stress.

Authors:  Laura Giusti; Cristina Angeloni; Maria Cristina Barbalace; Serena Lacerenza; Federica Ciregia; Maurizio Ronci; Andrea Urbani; Clementina Manera; Maria Digiacomo; Marco Macchia; Maria Rosa Mazzoni; Antonio Lucacchini; Silvana Hrelia
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

6.  A comparison of LKB1/AMPK/mTOR metabolic axis response to global ischaemia in brain, heart, liver and kidney in a rat model of cardiac arrest.

Authors:  Shohreh Majd; John H T Power; Timothy K Chataway; Hugh J M Grantham
Journal:  BMC Cell Biol       Date:  2018-06-19       Impact factor: 4.241

7.  Evolutionarily conserved susceptibility of the mitochondrial respiratory chain to SDHI pesticides and its consequence on the impact of SDHIs on human cultured cells.

Authors:  Paule Bénit; Agathe Kahn; Dominique Chretien; Sylvie Bortoli; Laurence Huc; Manuel Schiff; Anne-Paule Gimenez-Roqueplo; Judith Favier; Pierre Gressens; Malgorzata Rak; Pierre Rustin
Journal:  PLoS One       Date:  2019-11-07       Impact factor: 3.240

Review 8.  Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes.

Authors:  Gabriela Dumitrita Stanciu; Razvan Nicolae Rusu; Veronica Bild; Leontina Elena Filipiuc; Bogdan-Ionel Tamba; Daniela Carmen Ababei
Journal:  Biomedicines       Date:  2021-05-19

Review 9.  Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.

Authors:  Henry Querfurth; Han-Kyu Lee
Journal:  Mol Neurodegener       Date:  2021-07-02       Impact factor: 14.195

Review 10.  Fighting the Cause of Alzheimer's and GNE Myopathy.

Authors:  Shreedarshanee Devi; Rashmi Yadav; Pratibha Chanana; Ranjana Arya
Journal:  Front Neurosci       Date:  2018-10-15       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.